Underrepresentation of individuals with limited English proficiency who speak Spanish is ongoing in phase 3 biomedical clinical trials and exacerbates health inequity.

Tabitha E. H. Moses, MS joins Ethics Talk to discuss her article, coauthored with Dr Arash Javanbakht: “How Should Clinicians Determine a Traumatized Patient’s Readiness to Return to Work?”

Children with micronutrient deficiency might need supplementation, sometimes in irregularly high doses.

Some allopathic clinicians’ biases influence the information they draw upon to make decisions and offer recommendations.

Illegal, fraudulent, adulterated, or improperly labeled products should be regarded as sources of possible clinical and ethical harm to patients.

During or after conflict, a clinician might be required to provide evidence to an official investigatory body or court.

Systematic analysis of extant research ethics guidance is needed for conflict-affected countries and UN agencies.

Dr Alexander Ding joins Ethics Talk to discuss his article, coauthored with Dr Amy B. Cadwallader and other members of the AMA Council on Science and Public Health: “Which Features of Dietary Supplement Industry, Product Trends, and Regulation Deserve Physicians’ Attention?”

Professor Leonard Rubenstein joins Ethics Talk to discuss his article, coauthored with Dr Rohini Haar: “What Does Ethics Demand of Health Care Practice in Conflict Zones?”

Inequitable care and outcomes experienced by persons with mental illness have long been exacerbated by stigma expressed by clinicians.